AMERIPRISE FINANCIAL INC

Position in HROW — Harrow, Inc.

CIK 820027 MINNEAPOLIS, MN

Position in HROW

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$877,090

+$473,363 QoQ

Shares Held

20,652

+80.4% QoQ

Ownership

0.055%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#89

of 223 holders

Holding Since

Jun 2022

12 quarters on record

Voting authority Sole 0% Shared 51% None 49%

Healthcare · as of Jun 30, 2026

AMERIPRISE FINANCIAL INC holds $802,494,373 across 36 Drug Manufacturers - Specialty & Generic names. HROW ranks #27 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VTRS	Viatris Inc	18,815,747	$298,794,060
2	NBIX	Neurocrine Biosciences Inc	502,267	$84,652,078
3	LNTH	Lantheus Holdings, Inc.	619,298	$68,704,917
4	UTHR	UNITED THERAPEUTICS Corp	123,215	$66,761,581
5	ZTS	Zoetis Inc.	812,181	$58,363,324
6	ELAN	Elanco Animal Health Inc	1,396,427	$34,366,066
7	ALKS	Alkermes plc.	630,325	$33,029,029
8	AMRX	Amneal Pharmaceuticals, Inc.	1,581,869	$27,382,151

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$877,090	20,652	+80.4%	Shares	Defined	2026-08-14
2026-03-31	$403,727	11,450	-0.8%	Shares	Defined	2026-05-15
2025-12-31	$565,705	11,545	+9.7%	Shares	Defined	2026-02-17
2025-09-30	$507,094	10,525	-81.8%	Shares	Defined	2025-11-14
2024-03-31	$764,032	57,750	-2.2%	Shares	Defined	2024-05-15
2023-12-31	$661,102	59,027	-10.9%	Shares	Defined	2024-02-14
2023-09-30	$952,084	66,255	-0.9%	Shares	Defined	2023-11-14
2023-06-30	$1,272,728	66,845	-31.6%	Shares	Defined	2023-08-14
2023-03-31	$2,069,214	97,789	-20.7%	Shares	Defined	2023-05-22
2022-12-31	$1,819,878	123,298	-1.2%	Shares	Defined	2023-02-14
2022-09-30	$1,505,660	124,744	+18.4%	Shares	Defined	2022-11-14
2022-06-30	$766,860	105,338	—	Shares	Defined	2022-08-15
No filing history on record for this holder in this stock.